Literature DB >> 11353893

[Involvement of the IGF system in the pathogenesis of adrenocortical tumors].

C Gicquel1, N Boulle, A Logié, N Bourcigaux, V Gaston, Y Le Bouc.   

Abstract

Adrenocortical carcinoma remains a challenge for the therapeutist; prognosis is ominous. Various abnormalities playing a pathogenetic role have been recently described in adrenocortical tumors. Among them, dysregulation of the IGF system and imprinting mistakes at the 11p15 locus play a determining role in malignant transformation of adrenocortical cells. These markers of the malignant phenotype might markedly improve our diagnosis and prognosis abilities.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11353893

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   2.478


  5 in total

1.  Single nucleotide polymorphism array profiling of adrenocortical tumors--evidence for an adenoma carcinoma sequence?

Authors:  Cristina L Ronchi; Silviu Sbiera; Ellen Leich; Katharina Henzel; Andreas Rosenwald; Bruno Allolio; Martin Fassnacht
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

2.  Insulin-like growth factor--phosphatidylinositol 3 kinase signaling in canine cortisol-secreting adrenocortical tumors.

Authors:  M M J Kool; S Galac; N van der Helm; S Corradini; H S Kooistra; J A Mol
Journal:  J Vet Intern Med       Date:  2015-01       Impact factor: 3.333

3.  The insulin and igf-I pathway in endocrine glands carcinogenesis.

Authors:  Roberta Malaguarnera; Alaide Morcavallo; Antonino Belfiore
Journal:  J Oncol       Date:  2012-08-08       Impact factor: 4.375

4.  The emerging role of the molecular marker p27 in the differential diagnosis of adrenocortical tumors.

Authors:  Sofia S Pereira; Tiago Morais; Madalena M Costa; Mariana P Monteiro; Duarte Pignatelli
Journal:  Endocr Connect       Date:  2013-08-28       Impact factor: 3.335

5.  IGF2 role in adrenocortical carcinoma biology.

Authors:  Sofia S Pereira; Mariana P Monteiro; Madalena M Costa; Ângela Moreira; Marco G Alves; Pedro F Oliveira; Ivana Jarak; Duarte Pignatelli
Journal:  Endocrine       Date:  2019-08-04       Impact factor: 3.633

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.